Annelise Bennaceur

Annelise Bennaceur

Company: iPSirius

Job title: Chief Scientific Officer

Seminars:

Revolutionizing the Treatment of Solid Tumors Utilizing iPSCs to Unlock Treatments for a New Frontier of Oncology 2:00 pm

Engineering iPSCs designed to target and treat solid tumors as a promising new approach to cancer treatment Utilizing iPSCs to address the three major hurdles associated with cancer treatment: metastasis, treatment resistance, and relapse Combating the tumor microenvironment using iPSCs to stimulate a stronger immune responseRead more

day: Day Two Track A PM

Roundtable Discussion: Implementing GMP Compatible Practices into Preclinical iPSC Research 2:30 pm

Integrating GMP principles and processes into preclinical iPSC research workflows to enhance the development of treatments for solid tumors and ensure a smooth transition to clinical development Addressing the challenges of sourcing GMP-grade reagents and adapting research protocols to meet the specific needs of solid tumor treatments and aligning with large-scale manufacturing requirements for future clinical trialsRead more

day: Day Two Track A PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.